Zdrowie i gospodarka · 08/11/2016
FDA Clears Verapamil Hydrochloride Extended-Release Oral Tablet for Approval
The US Food and Drug Administration (FDA) has officially determined that the 180mg CALAN SR (verapamil hydrochloride) extended-release oral tablet was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of generic versions.